Dissecting PTPN7-driven aggressiveness in IDH-wildtype astrocytomas: multi-omics, clinical validation, and spatial transcriptomics for prognostic insights.

{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:40413344", "kind": "science-record", "revision": 3, "content_hash": "sha256:d37523c4baf56019b4f87ba948dae48491e1c98a964021e6a9b29bc67ffe3422", "created_at": "2026-11-01T20:30:33Z", "updated_at": "2026-11-01T22:14:06Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Dissecting PTPN7-driven aggressiveness in IDH-wildtype astrocytomas: multi-omics, clinical validation, and spatial transcriptomics for prognostic insights.", "doi": "10.1007/s12672-025-02662-5", "pmid": "40413344", "authors": ["Tung Liu", "Yu-Chieh Lin", "Pei-Chi Chang", "Dueng-Yuan Hueng", "Yao-Feng Li"], "journal": "Discover oncology", "year": 2025, "abstract": "BACKGROUND: Gliomas, particularly IDH-wildtype astrocytomas, remain highly aggressive and resistant to current therapies. Despite advances in molecular classification, effective therapeutic targets are still limited. Consequently, identifying new targets is essential to improve patient survival. PTPN7, a tyrosine phosphatase implicated in MAPK signaling, is known to play roles in various malignancies but remains underexplored in gliomas. This study examines the prognostic significance, spatial distribution, and immune-related functions of PTPN7, aiming to elucidate its potential as a prognostic role and therapeutic target in glioma treatment.\nMATERIALS AND METHODS: We analyzed PTPN7 mRNA expression in gliomas via TCGA, CGGA, and single-cell RNA sequencing (GSE131928 and GSE89567). Kaplan determined prognostic significance-Meier and uni-/multi-variate Cox survival analyses. Gene set enrichment analysis (GSEA) was used to identify dysregulated pathways, immune signatures, and cell-type enrichments. We also applied CIBERSORT to evaluate the relationships between PTPN7 expression and 12-principal cell states and 22 immune populations. Spatial transcriptomics (Ivy Glioblastoma Atlas, 10 × Genomics Visium) mapped PTPN7 distribution; these findings were corroborated by immunohistochemistry-validated protein expression in 70 cases.\nRESULTS: Pan-cancer analysis revealed PTPN7 overexpression in multiple malignancies, including glioma. Notably, PTPN7 was significantly elevated in IDH-wildtype astrocytomas, correlating with higher tumor grades and poorer overall survival. GSEA indicated that high PTPN7 is linked to T-cell differentiation, macrophage/monocyte activation, and dendritic cell-associated pathways. Both immune deconvolution and single-cell analyses showed that PTPN7 positively correlates with myeloid series and T-cell populations, supported by additional GSEA findings. In the Ivy dataset and spatial transcriptomics, PTPN7 was concentrated in peri-necrotic, cellular tumor, and slightly lower in the infiltrating border regions, consistent with immune interaction sites. Immunohistochemical data further demonstrated high PTPN7 expression tracks with increased tumor grade, reaching statistical significance in IDH-wildtype astrocytomas and confirming its clinical relevance.\nCONCLUSION: This study positions PTPN7 as a prognostic biomarker and immune modulator in gliomas, particularly IDH-wildtype astrocytomas. Its expression correlates with tumor aggressiveness and immune infiltration, potentially driving glioma progression. Targeting PTPN7 may disrupt immune evasion and support tumor eradication, indicating a promising therapeutic avenue in immunotherapy-based strategies.", "claims": [{"id": "claim-method", "statement": "A meta‐analysis integrating data from CGGA and TCGA glioma cohorts revealed that high PTPN7 expression correlates with poorer survival (common‐effect HR = 1.30, 95% CI 1.16–1.46, p < 0.001, Fig. 3A).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:40413344", "locator": "sections[13] \"Integrating meta-analysis, prognostic modeling, and genomic exploration of PTPN7 in glioma\" paragraph 2", "quote": "A meta‐analysis integrating data from CGGA and TCGA glioma cohorts revealed that high PTPN7 expression correlates with poorer survival (common‐effect HR = 1.30, 95% CI 1.16–1.46, p < 0.001, Fig. 3A)."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Datasets used in this project can be accessed via the TCGA GDC portal (https://portal.gdc.cancer.gov/), CGGA (http://www.cgga.org.cn/), Ivy Glioblastoma Atlas (https://glioblastoma.alleninstitute.org/) and the Single-cell sequencing data from Gene-Expression Omnibus (GEO) databases, GSE131928 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131928) and GSE89567 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89567). Glioblastoma Visium dataset (https://www.10xgenomics.com/datasets/human-glioblastoma-whole-transcriptome-analysis-1-standard-1-2-0).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:40413344", "locator": "sections[32] \"notes\" paragraph 1", "quote": "Datasets used in this project can be accessed via the TCGA GDC portal (https://portal.gdc.cancer.gov/), CGGA (http://www.cgga.org.cn/), Ivy Glioblastoma Atlas (https://glioblastoma.alleninstitute.org/) and the Single-cell sequencing data from Gene-Expression Omnibus (GEO) databases, GSE131928 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131928) and GSE89567 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89567). Glioblastoma Visium dataset (https://www.10xgenomics.com/datasets/human-glioblastoma-whole-transcriptome-analysis-1-standard-1-2-0)."}], "state": "complete"}, {"id": "claim-target-result", "statement": "A meta‐analysis integrating data from CGGA and TCGA glioma cohorts revealed that high PTPN7 expression correlates with poorer survival (common‐effect HR = 1.30, 95% CI 1.16–1.46, p < 0.001, Fig. 3A).", "kind": "quantitative", "target": {"value": 95.0, "unit": "per cent", "tolerance": null, "source": "A meta‐analysis integrating data from CGGA and TCGA glioma cohorts revealed that high PTPN7 expression correlates with poorer survival (common‐effect HR = 1.30, 95% CI 1.16–1.46, p < 0.001, Fig. 3A)."}, "evidence": [{"asset": "source:pmid:40413344", "locator": "sections[13] \"Integrating meta-analysis, prognostic modeling, and genomic exploration of PTPN7 in glioma\" paragraph 2", "quote": "A meta‐analysis integrating data from CGGA and TCGA glioma cohorts revealed that high PTPN7 expression correlates with poorer survival (common‐effect HR = 1.30, 95% CI 1.16–1.46, p < 0.001, Fig. 3A)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "A meta‐analysis integrating data from CGGA and TCGA glioma cohorts revealed that high PTPN7 expression correlates with poorer survival (common‐effect HR = 1.30, 95% CI 1.16–1.46, p < 0.001, Fig. 3A).", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:40413344"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:accession_absent", "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:accession_absent"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:40413344", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1007/s12672-025-02662-5", "sha256": "sha256:8521381bc51ae8c971091cfafac7dd3e0c4aeb5b047d1cf549c950a15336d97a", "bytes": 47934, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1007/s12672-025-02662-5", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC12103406", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}], "gaps": []}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "differential_expression", "specific": "limma_voom", "label": "Differential expression analysis", "dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["count_matrix_with_condition"], "evidence": {"score": 0.8, "band": "high", "quote": "limma"}}, {"id": "method-2", "family": null, "specific": null, "label": "Meta‐analysis integrating data from CGGA and TCGA glioma cohorts", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "A meta‐analysis integrating data from CGGA and TCGA glioma cohorts revealed that high PTPN7 expression correlates with poorer survival (common‐effect HR = 1.30, 95% CI 1.16–1.46, p < 0.001, Fig. 3A)."}}], "targets": [{"id": "target-published-estimate", "claim_id": "claim-target-result", "operation": "differential_expression_fit", "expected_value": 95.0, "unit": "per cent", "tolerance": null, "state": "complete", "note": "The published estimate as the reader quoted it from the paper. No tolerance is published because the paper states none."}, {"id": "target-published-estimate-hazard-ratio", "claim_id": "claim-target-result", "operation": "differential_expression_fit", "expected_value": 1.3, "unit": "hazard ratio", "tolerance": null, "state": "complete", "note": "The published estimate as the reader quoted it from the paper. No tolerance is published because the paper states none."}, {"id": "target-published-estimate-p-value", "claim_id": "claim-target-result", "operation": "differential_expression_fit", "expected_value": 0.001, "unit": "p-value", "tolerance": null, "state": "complete", "note": "The threshold the paper applied to its own result, as the paper states it. A run that reproduces the effect is judged against this threshold."}], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "blocked", "tier": "R4", "blocking_axis": "data", "blocked_on": "data:accession_absent", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: limma_voom."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R4", "reachable": false, "accessions": [], "resolved_accessions": [], "statements": ["Datasets used in this project can be accessed via the TCGA GDC portal (https://portal.gdc.cancer.gov/), CGGA (http://www.cgga.org.cn/), Ivy Glioblastoma Atlas (https://glioblastoma.alleninstitute.org/) and the Single-cell sequencing data from Gene-Expression Omnibus (GEO) databases, GSE131928 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE131928) and GSE89567 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE89567). Glioblastoma Visium dataset (https://www.10xgenomics.com/datasets/human-glioblastoma-whole-transcriptome-analysis-1-standard-1-2-0)."], "basis": "The paper names no accession to its source data, so the data has to come from the authors."}}, "can_run": {"dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "assets": ["source:pmid:40413344"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:None"]}, "gaps": ["data:accession_absent"]}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:52:59Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 13368, "completion_tokens": 1720, "cached_tokens": 264}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:40413344", "type": "paper", "label": "pmid:40413344"}, {"id": "source:pmid:40413344", "type": "manuscript", "label": "PMID 40413344 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:40413344", "type": "paper", "label": "pmid:40413344"}, {"id": "source:pmid:40413344", "type": "manuscript", "label": "PMID 40413344 full text"}, {"id": "data:geo:None", "type": "dataset", "label": "GEO None"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-40413344", "type": "extraction", "used": ["source:pmid:40413344"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-None", "type": "accession_resolution", "used": ["data:geo:None"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:40413344", "parent_hash": "sha256:ae91d084a04ca95e1fc83e9a49699ecbc1922c3e71a894d457fcf6be907de104", "fork_of": null, "generation": 2}, "gaps": ["execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:obtain_source_data blocked on data:accession_absent"], "assays": [{"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ibution; these findings were corroborated by immunohistochemistry-validated protein expression in 70 cases. RE", "s, consistent with immune interaction sites. Immunohistochemical data further demonstrated high PTPN7 express"], "order_basis": "paper_text_order:1394", "id": "assay:1"}, {"role": "analysis", "definition_id": "differential_expression", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.8, "evidence": ["limma"], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}